Nasal Antiseptics Market size was over USD 353.92 million in 2024 and is poised to exceed USD 692.59 million by 2037, witnessing over 5.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of nasal antiseptics is evaluated at USD 368.93 million. The market is growing as a result of the increasing usage of antiseptic products for pre- and post-operative treatments. Antiseptic solutions are increasingly being used in pre-operative and post-operative procedures to reduce healthcare-acquired infections (HAIs) and surgical site infections (SSIs). Antimicrobial resistance and illnesses linked to healthcare have an incalculable effect on people's lives. In one of the studies conducted in 2022, it was found that the postoperative infection rate following endoscopic sinus surgery was 10%.
Chronic infections last longer than 90 days, while acute sinus infections resolve within 30 days. Early detection of this illness involves physical examination of the nasal septum, polyps, and mucosa. To treat this infection, you may need an MRI, CT, or ultrasound scan. Corticosteroids, antibiotics, sulfonamides, painkillers, and antihistamines are common medications used to treat sinusitis. The most often-used medications for nasal decontamination include prednisone, mometasone, fluticasone, and triamcinolone.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.3% |
|
Base Year Market Size (2024) |
USD 353.92 million |
|
Forecast Year Market Size (2037) |
USD 692.59 million |
|
Regional Scope |
|
Type (Interferons, Povidone-Iodine, Lactoferrin, Alcohol)
Alcohol segment for the nasal antiseptics market is anticipated to hold the largest share of 45% during the forecast period. Because alcohol-based nasal antiseptics effectively eradicate bacteria and germs from nasal passages, their use is becoming more and more common. By acting as a disinfectant, alcohol helps to lower the risk of infection and encourage good nose hygiene. Alcohol-based antiseptics are also well-known for drying quickly, which makes them practical and simple to use. The need for alcohol-based nasal antiseptics is growing as people's awareness of personal cleanliness rises. Furthermore, most people handle alcohol-based antiseptics well and don't have any irritation in their nasal passages. Furthermore, according to a report, nasal decontamination with an alcohol-based nasal antiseptic— hand sanitizer with a nose-specific formulation—is another crucial tactic used in hundreds of US hospitals. Because it targets bacteria that have the potential to cause infections at their source, this straightforward tactic works well. Therefore, these factors are propelling the growth of the segment.
Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies)
Nasal antiseptics market of hospital pharmacies segment is poised to hold a share of 43% during the projected period. Hospitals are providing more specialized treatments and procedures as well as a wider range of healthcare services. Also, growing investment in healthcare globally is propelling the growth of the segment. By 2022, global health spending was predicted to reach over USD 10 trillion. The increase in hospital pharmacies can be attributed to the need for a greater stock of pharmaceuticals and drugs, such as nasal antiseptics, to support this expansion. Hospital pharmacies offer patients a practical means of obtaining their prescription drugs while undergoing medical treatment at the hospitals. In addition, hospital pharmacies collaborate closely with medical staff, such as physicians and nurses, to guarantee that nasal antiseptics are distributed and used appropriately. By working together, it is possible to guarantee that the appropriate nasal antiseptics are available for different patient demands and medical procedures.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Distribution Channel |
|
North American Market Forecast
North America industry is estimated to hold largest revenue share of 36% by 2037. The market is growing as a result of rising sinus infection prevalence and awareness as well as rising healthcare costs. As per a report, 31 million Americans suffer from sinusitis. To cure it, North Americans spend over USD 1 billion annually on over-the-counter drugs. Furthermore, significant R&D efforts and efforts by important players to provide sophisticated and reasonably priced nasal antiseptics are driving significant market expansion in the United States. Infections can also spread due to factors including urbanization, increasing travel, and crowded living situations. Nasal antiseptics are becoming more and more well-liked in the area since they offer people an easy and preventative technique to shield themselves from infectious infections.
European Market Statistics
Nasal antiseptics market in Europe is anticipated to hold a share of 27% by the end of 2037. There is a growing awareness among the population about the importance of nasal hygiene and its role in preventing infections. Also, nasal antiseptics are effective in reducing the risk of respiratory infections, including colds, flu, and, even more serious infections like MRSA. Therefore, with the rise in these diseases, the market is expected to grow majorly in the region. Furthermore, nasal antiseptics are widely used in healthcare settings, such as hospitals and clinics, to reduce the spread of infections. Therefore, altogether these factors are contributing to the expansion of the market in Europe.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?